Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy

Author:

Hardy Rowan S1,Zhou Hong2,Seibel Markus J234,Cooper Mark S345

Affiliation:

1. University of Birmingham, Birmingham, United Kingdom

2. Bone Research Program, ANZAC Research Institute, Sydney, New South Wales, Australia

3. Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney, New South Wales, Australia

4. Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia

5. Adrenal Steroid Laboratory, ANZAC Research Institute, Sydney, New South Wales, Australia

Publisher

The Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference262 articles.

1. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism);Cushing;Bull Johns Hopkins Hosp,1932

2. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force;Strehl;Ann Rheum Dis,2016

3. Use of oral corticosteroids and risk of fractures;Van Staa;J Bone Miner Res,2000

4. The impact of oral corticosteroid use on bone mineral density and vertebral fracture;Walsh;Am J Respir Crit Care Med,2002

5. Bone loss in inflammatory disorders;Hardy;J Endocrinol,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3